1 Guidance

1 Guidance

1.1 Trabectedin is recommended as a treatment option for people with advanced soft tissue sarcoma if:

  • treatment with anthracyclines and ifosfamide has failed or

  • they are intolerant of or have contraindications for treatment with anthracyclines and ifosfamide

    and

  • the acquisition cost of trabectedin for treatment needed after the fifth cycle is met by the manufacturer.

  • National Institute for Health and Care Excellence (NICE)